Overview

Treating Nocturnal Hypertension and Nocturia in African American Men

Status:
Withdrawn
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This is a protocol to obtain pilot data to submit a new NIH grant on Nocturnal Hypertension and Nocturia. In the diversity supplement to Dr. Victor's current NIH grant (Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study) the results show that uncontrolled systolic hypertension is an independent determinant of nocturia in African American men. the investigators now want to pursue this correlation by designing a new NIH grant proposal to determine whether replacing short acting with long acting drugs and dosing them at bedtime rather than in the morning will: A. Lower systolic blood pressure during sleep B. Improve nocturia and result in better sleep quality
Phase:
Phase 4
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Treatments:
Sodium Chloride Symporter Inhibitors